Cue Biopharma, Inc.
CUE · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $61,398 | $120,793 | $101,600 | $353,838 |
| - Cash | $22,459 | $48,514 | $51,614 | $64,371 |
| + Debt | $8,876 | $14,695 | $19,316 | $10,053 |
| Enterprise Value | $47,815 | $86,974 | $69,301 | $299,520 |
| Revenue | $9,287 | $5,490 | $1,245 | $14,941 |
| % Growth | 69.2% | 341% | -91.7% | – |
| Gross Profit | $9,287 | -$32,607 | $1,245 | $16,719 |
| % Margin | 100% | -593.9% | 100% | 111.9% |
| EBITDA | -$37,528 | -$46,052 | -$50,491 | -$45,444 |
| % Margin | -404.1% | -838.8% | -4,055.5% | -304.1% |
| Net Income | -$40,674 | -$50,733 | -$53,010 | -$44,161 |
| % Margin | -438% | -924.1% | -4,257.8% | -295.6% |
| EPS Diluted | -0.72 | -1.11 | -1.49 | -1.41 |
| % Growth | 35.1% | 25.5% | -5.7% | – |
| Operating Cash Flow | -$36,329 | -$39,961 | -$41,806 | -$38,837 |
| Capital Expenditures | -$66 | $0 | -$171 | -$913 |
| Free Cash Flow | -$36,395 | -$39,961 | -$41,977 | -$39,750 |